These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15135717)

  • 1. Validation of the i-STAT handheld activated clotting time for use with bivalirudin.
    Schussler JM; Lander SR; Wissinger LA; Anwar A; Donsky MS; Johnson KB; Vallabhan RC; Wischmeyer JB
    Am J Cardiol; 2004 May; 93(10):1318-9. PubMed ID: 15135717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations.
    Cho L; Kottke-Marchant K; Lincoff AM; Roffi M; Reginelli JP; Kaldus T; Moliterno DJ
    Am J Cardiol; 2003 May; 91(9):1110-3. PubMed ID: 12714157
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimizing management of hirudin anticoagulation.
    Measday MA; Zucker ML; Pan CM; LaDuca FM
    J Extra Corpor Technol; 2005 Mar; 37(1):66-70. PubMed ID: 15804161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration.
    Casserly IP; Kereiakes DJ; Gray WA; Gibson PH; Lauer MA; Reginelli JP; Moliterno DJ
    Thromb Res; 2004; 113(2):115-21. PubMed ID: 15115666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass.
    Davis Z; Anderson R; Short D; Garber D; Valgiusti A
    Ann Thorac Surg; 2003 Jan; 75(1):264-5. PubMed ID: 12537226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of patients' bivalirudin plasma levels by a thrombelastograph ecarin clotting time assay: a comparison to a standard activated clotting time.
    Carroll RC; Chavez JJ; Simmons JW; Snider CC; Wortham DC; Bresee SJ; Cohen E
    Anesth Analg; 2006 May; 102(5):1316-9. PubMed ID: 16632802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.
    Paniccia R; Fedi S; Carbonetto F; Noferi D; Conti P; Bandinelli B; Giusti B; Evangelisti L; Pretelli P; Palmarini MF; Abbate R; Prisco D
    Anesthesiology; 2003 Jul; 99(1):54-9. PubMed ID: 12826842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability.
    Dirkmann D; Nagy E; Britten MW; Peters J
    BMC Anesthesiol; 2019 Sep; 19(1):174. PubMed ID: 31492108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of a modified ACT test to levels of bivalirudin used during cardiac surgery.
    Zucker ML; Koster A; Prats J; Laduca FM
    J Extra Corpor Technol; 2005 Dec; 37(4):364-8. PubMed ID: 16524153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant.
    Baker T; Chan R; Hill F
    J Extra Corpor Technol; 2004 Dec; 36(4):371-4. PubMed ID: 15679282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of monitoring activated clotting time when bivalirudin is used as the sole anticoagulation agent for percutaneous coronary intervention.
    Cheneau E; Canos D; Kuchulakanti PK; Rha SW; Satler LF; Suddath WO; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2004 Sep; 94(6):789-92. PubMed ID: 15374791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma-modified ACT can be used to monitor bivalirudin (Angiomax) anticoagulation for on-pump cardiopulmonary bypass surgery in a patient with heparin-induced thrombocytopenia.
    Jabr K; Johnson JH; McDonald MH; Walsh DL; Martin WD; Johnson AC; Pickett JM; Shantha-Martin U
    J Extra Corpor Technol; 2004 Jun; 36(2):174-7. PubMed ID: 15334761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation.
    Chia S; Van Cott EM; Raffel OC; Jang IK
    Thromb Haemost; 2009 Mar; 101(3):535-40. PubMed ID: 19277416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin.
    Tanaka KA; Szlam F; Sun HY; Taketomi T; Levy JH
    Anesth Analg; 2007 Oct; 105(4):933-9, table of contents. PubMed ID: 17898368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
    Lincoff AM; Bittl JA; Kleiman NS; Sarembock IJ; Jackman JD; Mehta S; Tannenbaum MA; Niederman AL; Bachinsky WB; Tift-Mann J; Parker HG; Kereiakes DJ; Harrington RA; Feit F; Maierson ES; Chew DP; Topol EJ;
    Am J Cardiol; 2004 May; 93(9):1092-6. PubMed ID: 15110198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin in acute coronary syndromes.
    Sanmartin M
    N Engl J Med; 2007 Mar; 356(10):1069-70; author reply 1070-1. PubMed ID: 17347463
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.
    Stone GW; Bertrand M; Colombo A; Dangas G; Farkouh ME; Feit F; Lansky AJ; Lincoff AM; Mehran R; Moses JW; Ohman M; White HD
    Am Heart J; 2004 Nov; 148(5):764-75. PubMed ID: 15523305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalirudin anticoagulation in neonates and infants undergoing cardiac surgery.
    Hasija S; Hote MP; Makhija N; Chauhan S; Malhotra P; Khan MA; Sharma G
    J Cardiothorac Vasc Anesth; 2022 Oct; 36(10):3841-3846. PubMed ID: 35817672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bivalirudin (Angiomax) for angioplasty.
    Med Lett Drugs Ther; 2001 Apr; 43(1103):37-8. PubMed ID: 11331441
    [No Abstract]   [Full Text] [Related]  

  • 20. Bivalirudin, blood loss, and graft patency in coronary artery bypass surgery.
    Merry AF
    Semin Thromb Hemost; 2004 Jun; 30(3):337-46. PubMed ID: 15282656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.